CoChat

TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis

Open access
Pang, Yanli, Gara, Sudheer Kumar, Achyut, Bhagelu R., Li, Zhaoyang, Yan, Hannah H., Day, Chi-Ping, Weiss, Jonathan M., Trinchieri, Giorgio, Morris, John C., Yang, Li · 2013 · Cancer Discovery
Cited by 157

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

TGF-β is overexpressed in advanced human cancers. It correlates with metastasis and poor prognosis. However, TGF-β functions as both a tumor suppressor and a tumor promoter. Here, we report for the first time that genetic deletion of Tgfbr2 specifically in myeloid cells (Tgfbr2MyeKO) significantly inhibited tumor metastasis. Reconstitution of tumor-bearing mice with Tgfbr2MyeKO bone marrow recapitulated the inhibited metastasis phenotype. This effect is mediated through decreased production of type II cytokines, TGF-β1, arginase 1, and inducible nitric oxide synthase, which promoted IFN-γ production and improved systemic immunity. Depletion of CD8 T cells diminished the metastasis defect in the Tgfbr2MyeKO mice. Consistent with animal studies, myeloid cells from patients with advanced-stage cancer showed increased TGF-β receptor II expression. Our studies show that myeloid-specific TGF-β signaling is an essential component of the metastasis-promoting puzzle of TGF-β. This is in contrast to the previously reported tumor-suppressing phenotypes in fibroblasts, epithelial cells, and T cells. Significance: Our study identifies myeloid-specific TGF-β signaling as a critical mediator in tumor metastasis, distinct from the tumor-suppressive effect of TGF-β signaling in epithelial cells, fibroblasts, and T cells. We further provide mechanistic insight into host antitumor immunity and suggest a cell type–specific cancer-targeting strategy. Cancer Discov; 3(8); 936–51. ©2013 AACR. See related commentary by Souza-Fonseca-Guimaraes and Smyth, p. 846 This article is highlighted in the In This Issue feature, p. 826

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-12-0527

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 157

Metadata

Authors
Pang, Y., Gara, S. K., Achyut, B. R., Li, Z., Yan, H. H., Day, C.-P., Weiss, J. M., Trinchieri, G., Morris, J. C., & Yang, L.
Venue
Cancer Discovery
Published
2013-08-01
Volume
3
Issue
8
Pages
936-951
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2136000914
Cited by
157
References
19
FWCI
5.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis. https://app.cochat.ai/papers/10.1158/2159-8290.cd-12-0527
The paper
Pang, Y., Gara, S. K., Achyut, B. R., Li, Z., Yan, H. H., Day, C.-P., Weiss, J. M., Trinchieri, G., Morris, J. C., & Yang, L. (2013). TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-12-0527

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.